Date: 22-Aug-2019

Teva launches generic version of EpiPen for young children

Teva Pharmaceutical Industries Ltd on Tuesday made its generic version of Mylans EpiPen for young children available in most retail pharmacies at $300 for a 2-pack. U.S-listed shares of the Israel-based company rose 4.9% to $7 in afternoon trading. Teva, the worlds largest generic drugmaker, is already selling the product for adults, after getting U.S. approval for its copy of EpiPen last August, following several years of delay.